Why Walgreens Boots Alliance Soared Today

Motley Fool
2024-12-11
  • Rumors are that a major private equity firm is circling Walgreens.
  • The stock is down over 60% over the past year and even more from all-time highs.
  • The company has struggled to turn itself around under a new CEO.

Shares of Walgreens Boots Alliance (WBA 18.64%) soared 20% on Tuesday, as of 2:35 p.m. ET.

The beaten-down retail pharmacy rallied on rumors it might get bought out by a private equity firm. Usually, buyouts happen at a premium to the market stock price, and with shares down 63% on the year and 90% from their highs, there was ample room for a premium over yesterday's closing stock price.

Private equity to the rescue?

Today, The Wall Street Journal reported that private equity firm Sycamore Partners has been in talks with Walgreens regarding a potential buyout. The WSJ reported that according to "people familiar with the matter," talks could be consummated by the early part of next year.

Walgreens is much smaller than the $100 billion market cap reached in 2015, with its value falling to just $7.4 billion yesterday but vaulting to over $9 billion as of this writing. That would make it a large deal for Sycamore, but also doable, as private equity has attracted more investor money in recent years. That being said, Walgreens is also burdened by about $8 billion in net debt, not counting operating leases.

Walgreens has been attempting a turnaround under CEO Tim Wentworth, who comes from the pharmacy benefit manager (PBM) industry, whose tough negotiations on drug reimbursement has been a source of Walgreens' depleted margins.

While Wentworth recently said negotiations with PBMs to get better reimbursement rates are going well, other tech-savvy retailers and e-commerce players are also moving quickly to get into same-day pharmacy delivery services. That additional threat may require more investment from Walgreens to compete, and spending amid depressed revenue might scare public market investors. Apparently, Sycamore thinks it can help Walgreens turn itself around away from the prying eyes of the market.

Walgreens is riskier after today's bounce

Today's bounce indicates investors think a deal is likely, but further gains from here may be difficult. Walgreens is down a lot from highs, but also has great challenges that will probably limit the amount Sycamore is willing to pay. Meanwhile, if a deal doesn't occur, expect the stock to revisit its recent lows.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10